Invasive micropapillary carcinoma of the breast: a case report

Invasive micropapillary carcinoma of the breast is a rare subtype of invasive ductal carcinoma. It's clinical characteristics include a high rate of lymph node metastasis, vascular invasion, and poor prognosis. A 70-year-old postmenopausal woman presented with a lesion on the right breast that had been first noted by ultrasound examination. Physical examination revealed no palpable mass. An excisional biopsy was done, and the diagnosis was invasive micropapillary carcinoma. The patient underwent a right modified radical mastectomy with axillary dissection. Histologically, the tumor was composed of pseudopapillary structures in clear spaces lined by delicate strands of fibrocollagenous stroma. The pseudopapillary structures were devoid of fibrovascular cores. Estrogen receptor and progestrone receptor were positive in the tumor cells, C-erb-B2 and WT1 were negative. Tumor cells showed membranous and cytoplasmic expression of Ca125. In this case, we described a rare subtype of invasive ductal carcinoma and discussed the histopathological and immunohistochemical findings

Karaciğer kist hidatiğine laparoskopik cerrahi yaklaşım: Retrospektif çalışma

Karaciğer kist hidatiğinin tedavisinde laparoskopik yaklaşım, giderek önem kazanmakla birlikte, uzun dönem sonuçları alınmadığından halen tartışılmaktadır. Bu yazıda, kliniğimizde 1997-2002 yılları arasında laparoskopik cerrahi uyguladığımız 14 karaciğer kist hidatik olgusunu retrospektif olarak değerlendirdik. Sonuç olarak; karaciğer kist hidatiğinin cerrahi tedavisinde laparoskopik drenaj ve marsupiyalizasyonun oldukça güvenli ve etkin bir yöntem olduğu sonucuna ulaştık.However laparoscopic approach to treatment of hydatid cyst of liver gets more important increasingly, it's stili equivocal since long-term results have not been reported. in the present report, we evaluated 14 liver hidatid cyst cases that we treated with laparoscopic surgery between 1997 and 2002 years. As a result, we found that laparoscopic drainage and marsupalization is a fairly safe and effective method for surgical treatment of cyst hidatid of liver

Management of Encapsulated Blebs After Filtering Surgery

Pur po se: To evaluate the results of bleb needling of encapsulated blebs with 1% mitomycine-C (Mtm-C) after trabeculectomy surgery. Ma te ri al and Met hod: 98 eyes of 90 glaucoma patients who had undergone trabeculectomy between July 2009 and September 2011 were evaluated retrospectively. Twenty-five eyes of 24 patients who developed encapsulated bleb with at least 3-month follow-up were enrolled in the study. These patients had undergone bleb needling with 1% Mtm-C (16 eyes) since medications were not efficient for IOP control. The preand post-needling intraocular pressures (IOP) were compared with IOPs being controlled with anti-glaucoma medications (9 eyes). Re sults: Encapsulated bleb was seen in 25 (25.6%) eyes of 24 patients out of 98 eyes of 90 patients who had trabeculectomy. The mean age was 62.6±13.6 (23-83) years and the mean follow-up time was 5.7±4.4 (3-20) months. The mean time that encapsulated blebs were diagnosed was 4.1±1.5 (2.5-8) weeks after the trabeculectomy. The number of eyes with IOP controlled with medication only was 9 (36%) with 5.7±4.0 (3- 14) months mean follow-up time. Mtm-C 1% bleb needling was performed at mean 9.1±3.2 (3-15) weeks after trabeculectomy in 16 eyes (64%) which had uncontrolled IOP with medical treatment. The IOPs before surgery and at postoperative 1st week, 1st, 3rd, and 6th months were 26.5±8.6 mmHg, 11.9±2.6 (5-18) mmHg, 14.5±3.8 (11-20) mmHg, 15.2±5.6 (8-20) mmHg, and 14.8±1.4 (8-28) mmHg, respectively (p<0,01). The numbers of anti-glaucoma medication before surgery and at postoperative 1st week, 1st, 3rd, and 6th months of needling were 2.1±0.7, 0.3±1.2, 1.1±1.4, 0.7±1.2, and 1.3± 0.8, respectively (p<0.05). Dis cus si on: One of the complications which compromises the IOP reduction after filtrating glaucoma surgery is formation of encapsulated bleb. Needling of encapsulated bleb with 1% Mtm-C is a safe and efficient surgical treatment in patients who have inadequate IOP reduction with anti-glaucoma medications. (Turk J Ophthalmol 2013; 43: 173-7